Flow Diverting Stent Helps Contain Cerebrovascular Defects
|
By HospiMedica International staff writers Posted on 24 Jul 2018 |

Image: The Surpass Streamline Flow Diverter in proximity to an aneurysm (Photo courtesy of Stryker).
An innovative flow diverter embolization device protects susceptible patients from large and giant brain unruptured aneurysms.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
Latest Surgical Techniques News
- New Classification System Brings Clarity to Brain Tumor Surgery Decisions
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
- NIR Light Enables Powering and Communicating with Implantable Medical Devices
- Simple Bypass Protocol Improves Outcomes in Chronic Cerebral Occlusion
- Implantable Absorbable Sensor Detects Life-Threatening Complications After Intestinal Surgery
- New Study Findings Enable Improved Ventilation During Complex Lung Surgery
- 3D-Printed Blood Vessel Scaffolds Could Transform Heart Bypass Surgeries
Channels
Artificial Intelligence
view channelCritical Care
view channel
Intranasal Spray to Prevent Illnesses from Respiratory Viruses
Respiratory viruses such as influenza and COVID-19 hospitalize more than one million people in the U.S. each year, with many infections spreading through close contact in households, schools, and workplaces.... Read more
AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
Cancer patients who experience a heart attack face a uniquely dangerous combination of risks, including higher chances of death, bleeding, and repeat cardiac events. Because of this complexity, they have... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more
WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more







